#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA3281972	F	Antiviral activity against Encephalomyocarditis virus infected in CF-1 mouse assessed as host survival time ratio at 10 mg/kg, sc administered 28, 22, 2 hrs before and 2 hrs after virus inoculation	Encephalomyocarditis virus	53		organism-based format	Scientific Literature
2.	ALA3281973	F	Antiviral activity against Encephalomyocarditis virus infected in CF-1 mouse assessed as host survival time ratio at 50 mg/kg, sc administered 28, 22, 2 hrs before and 2 hrs after virus inoculation	Encephalomyocarditis virus	56		organism-based format	Scientific Literature
3.	ALA3281974	F	Antiviral activity against Encephalomyocarditis virus infected in CF-1 mouse assessed as host survival time ratio at 250 mg/kg, sc administered 28, 22, 2 hrs before and 2 hrs after virus inoculation	Encephalomyocarditis virus	53		organism-based format	Scientific Literature
4.	ALA3281975	F	Antiviral activity against Encephalomyocarditis virus infected in CF-1 mouse assessed as host survival time ratio at 50 mg/kg, po administered via gavage at 28, 22, 2 hrs before and 2 hrs after virus inoculation	Encephalomyocarditis virus	43		organism-based format	Scientific Literature
5.	ALA3281976	F	Antiviral activity against Encephalomyocarditis virus infected in CF-1 mouse assessed as host survival time ratio at 250 mg/kg, po administered via gavage as single dose at 22 to 28 hrs before virus inoculation	Encephalomyocarditis virus	44		organism-based format	Scientific Literature
6.	ALA3281978	F	In vitro antiviral activity against Herpesvirus hominis type 1 infected in African green monkey Vero cells assessed as log reduction of virus titer by cytopathologic assay (Rvb = 5)	Human alphaherpesvirus 1	2		organism-based format	Scientific Literature
7.	ALA3281979	F	In vivo antiviral activity against Herpesvirus hominis type 1 infected in po dosed white mouse assessed as suppression of raised, blister-like lesions	Human alphaherpesvirus 1	2		organism-based format	Scientific Literature
8.	ALA3284791	F	In vivo antiviral activity against Herpesvirus hominis type 1 infected in hairless mouse assessed as suppression of ulcerated zoster-like lesions development administered topically at 2, 4 and 6 hrs after virus inoculation followed by continuous treatment daily for 4 days four times a day at 2 hrs interval measured on 8th day post-infection	Human alphaherpesvirus 1	2		organism-based format	Scientific Literature
9.	ALA3284792	F	In vivo antiviral activity against Herpesvirus hominis type 1 infected in hairless mouse assessed as decrease in lesion score administered topically at 2, 4 and 6 hrs after virus inoculation followed by continuous treatment daily for 4 days four times a day at 2 hrs interval measured on 8th day post-infection	Human alphaherpesvirus 1	2		organism-based format	Scientific Literature
10.	ALA3284793	F	Induction of interferon induction in po dosed mouse serum	Mus musculus	2		organism-based format	Scientific Literature
11.	ALA3284794	F	Induction of interferon induction in sc dosed mouse serum	Mus musculus	2		organism-based format	Scientific Literature
12.	ALA3284795	F	Antiviral activity against Semliki forest virus infected in mouse	Semliki Forest virus	2		organism-based format	Scientific Literature
13.	ALA3284796	F	Antiviral activity against Vaccinia virus infected in mouse	Vaccinia virus	2		organism-based format	Scientific Literature
14.	ALA3284797	F	Antiviral activity against Influenza A virus A2 Jap/305 infected in mouse	Influenza A virus	1		organism-based format	Scientific Literature
15.	ALA3284798	F	Antiviral activity against Influenza A virus A0 (Pr8) infected in mouse	Influenza A virus	1		organism-based format	Scientific Literature
16.	ALA3284799	F	Antiviral activity against Venezuelan equine encephalitis virus infected in po dosed monkey assessed as reduction in viremia	Venezuelan equine encephalitis virus	2		organism-based format	Scientific Literature